(Q35818904)

10 August 2017

1 reference

title

Prevention and treatment of stroke in patients with hypertension (English)

1 reference

10 August 2017

1

Giuseppe Mancia

1 reference

10 August 2017

language of work or name

1 reference

1 May 2004

1 reference

10 August 2017

published in

Clinical Therapeutics

1 reference

10 August 2017

volume

26

1 reference

10 August 2017

issue

5

1 reference

10 August 2017

page(s)

631-648

1 reference

Stroke: how large a public health problem, and how can the neurologist help?

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Cognitive impairment after stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Neuropsychiatric consequences of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke: epidemiology, clinical picture, and risk factors--Part I of III.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke incidence and survival among middle-aged adults: 9-year follow-up of the Atherosclerosis Risk in Communities (ARIC) cohort.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Blood pressure, stroke, and coronary heart disease. Part 1, Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Diagnosis and treatment of ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Continuity after a stroke: implications of life-course disruption in old age.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Mood disorder following cerebrovascular accident

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Functional recovery and social outcome after cerebral infarction in young adults.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Treatment and secondary prevention of stroke: evidence, costs, and effects on individuals and populations.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke prevention: hypertension, diabetes, tobacco, and lipids

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Newer risk factors for stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke prevention: management of modifiable vascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Meta-analysis of relation between cigarette smoking and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Diabetes and the risk of stroke. The Honolulu Heart Program

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Diabetes mellitus: an independent risk factor for stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Preventing ischemic stroke. Current approaches to primary and secondary prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Cholesterol, diastolic blood pressure, and stroke: 13 000 strokes in 450 000 people in 45 prospective cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Leisure-time physical activity and ischemic stroke risk: the Northern Manhattan Stroke Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Endarterectomy for asymptomatic carotid stenosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke associated with sympathomimetics contained in over-the-counter cough and cold drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Antiphospholipid antibodies and stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Antibodies to the atherosclerotic plaque components beta2-glycoprotein I and heat-shock proteins as risk factors for acute cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Epidemiologic assessment of the role of blood pressure in stroke. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Modeling of risk factors for ischemic stroke. The Willis Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Primary prevention of stroke

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Atrial fibrillation as an independent risk factor for stroke: the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Blood pressure, systolic and diastolic, and cardiovascular risks. US population data

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Blood pressure, antihypertensive drug treatment and the risks of stroke and of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Is diastolic hypertension an independent risk factor for stroke in the presence of normal systolic blood pressure in the middle-aged and elderly?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Isolated systolic hypertension : prognostic information provided by pulse pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Increased pulse pressure and risk of heart failure in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Aortic stiffness is an independent predictor of fatal stroke in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

J-shaped relation between change in diastolic blood pressure and progression of aortic atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Association between local pulse pressure, mean blood pressure, and large-artery remodeling.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Hyperacute stroke therapy with tissue plasminogen activator

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

New evidence for stroke prevention: clinical applications

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

New evidence for stroke prevention: scientific review

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Ticlopidine and antiplatelet therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

A randomized trial comparing ticlopidine hydrochloride with aspirin for the prevention of stroke in high-risk patients. Ticlopidine Aspirin Stroke Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Efficacy of ticlopidine and aspirin for prevention of reversible cerebrovascular ischemic events. The Ticlopidine Aspirin Stroke Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Aspirin and ticlopidine for prevention of recurrent stroke in black patients: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Reduction of stroke events with pravastatin: the Prospective Pravastatin Pooling (PPP) Project

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre ra

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effect of HMGcoA reductase inhibitors on stroke. A meta-analysis of randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Hormone replacement therapy and the risk of stroke. Follow-up of a population-based cohort in Sweden.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

The demise of HRT? The long-term safety of hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

The Women's Health Initiative trial and stroke risk

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effect of estrogen plus progestin on stroke in postmenopausal women: the Women's Health Initiative: a randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

International Society of Hypertension (ISH)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Cardiovascular protection and blood pressure reduction: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Risk reduction for stroke and coronary events

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effect of Antihypertensive Treatment in Patients Having Already Suffered From Stroke : Gathering the Evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Blood pressure control in type 2 diabetes--what does the United KingdomProspective Diabetes Study (UKPDS) tell us?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Recent evidence on drug therapy of mild to moderate hypertension and decreased risk of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Antihypertensive drugs in very old people: a subgroup meta-analysis of randomised controlled trials. INDANA Group

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Comparison of active treatment and placebo in older Chinese patients with isolated systolic hypertension. Systolic Hypertension in China (Syst-China) Collaborative Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Active-control equivalence trials and antihypertensive agents

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Systolic and diastolic blood pressure control in antihypertensive drug trials

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Excess stroke among hypertensive men and women attributable to undertreatment of hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Survival in treated hypertension: follow up study after two decades

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Echocardiography, hypertension, and left ventricular mass

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Role of echocardiography and carotid ultrasonography in stratifying risk in patients with essential hypertension: the Assessment of Prognostic Risk Observational Survey

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Effects of losartan and atenolol on left ventricular mass and neurohormonal profile in patients with essential hypertension and left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Microalbuminuria as a predictive factor for cardiovascular events.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Left ventricular geometry and function in patients with essential hypertension and microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

Novel AT(1) receptor-independent functions of losartan.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-2918%2804%2990065-3

7 January 2021

10.1016/S0149-2918(04)90065-3

Identifiers

DOI

1 reference

10 August 2017

1 reference